Last reviewed · How we verify
Oxygen constant flow
At a glance
| Generic name | Oxygen constant flow |
|---|---|
| Also known as | Oxygen |
| Sponsor | Laval University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ultra-Low-Flow Anesthesia and Carbon Footprint (NA)
- Retinal Blood Flow and Autoregulation (PHASE4)
- The Effects of Different Non-invasive Respiratory Support (NA)
- Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery (NA)
- Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease (NA)
- PROtective Ventilation With FLOW-Controlled Ventilation (NA)
- On-Demand Oxygen Delivery System Study (NA)
- Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intubation-free Survival in Acute Hypoxemic Respiratory Failure: the TRIPOD Randomized Clinical Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oxygen constant flow CI brief — competitive landscape report
- Oxygen constant flow updates RSS · CI watch RSS
- Laval University portfolio CI